Early use of immunomodulators prevents perianal disease in IBD kids

Early use of immunomodulators and biologic agents in paediatric Crohn’s disease reduces the risk of perianal disease by about 60% within two years, a US study shows A retrospective analysis of records for 2214 young people with CD under the age of 24 without perianal disease at baseline found that almost 20% developed perianal fistulising ...

Already a member?

Login to keep reading.

© 2021 the limbic